All email addresses at the HRA are changing in the coming weeks and this change will be complete by March 2020.
HRA staff email addresses will be standardised as firstname.lastname@hra.nhs.uk. A full list of contact email addresses for the Research Ethics Committees is now available here.
If you use the HRA staff member’s @nhs.net email address to contact them after they have moved to their new email address, you will receive a response containing their new details but your email won’t be automatically forwarded.
If you are unsure which contact information to use for the individual or service you require, please contact the HRA mainline on 020 797 22545 or use their contact form.
Make sure to check your junk mail if you are expecting emails from the HRA or an NHS REC as they often are sent there instead. Please add them to your safe senders list if this is the case to make sure you don’t miss any important study emails!
Health Research Authority public involvement guidance – third blog post
Health Research Authority #MakeItPublic Campaign – internal survey
Health Research Authority releases eLearning for student researchers
Health Research Authority public involvement guidance










New interdisciplinary research publication on Nepal
Methods of Researching Digital Harms and Cybercrime: An Interdisciplinary Symposium – Wednesday 15 July
Geography and Environmental Studies academics – would you like to get more involved in preparing our next REF submission?
Reminder: Recharge Your Research Routine Next Week for World Wellbeing Week
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease